ALNYLAM PHARMACEUTICALS, INC. Prepaid & Other Current Assets 2010-2025 | ALNY
What is prepaid & other current assets?
Prepaid and other current assets include advance payments and other assets expected to be consumed or converted to cash within one year.
What is ALNYLAM PHARMACEUTICALS, INC.'s current prepaid & other current assets?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual prepaid & other current assets for 2025 was $281.9M, a 141.01% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. prepaid & other current assets for the quarter ending December 31, 2025 was $281.9M.
What was ALNYLAM PHARMACEUTICALS, INC.'s prepaid & other current assets in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual prepaid & other current assets for 2024 was $117.0M, a 7.45% decline from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s prepaid & other current assets in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual prepaid & other current assets for 2023 was $126.4M, a 4.92% decline from 2022.
What is ALNYLAM PHARMACEUTICALS, INC.'s 5-year prepaid & other current assets CAGR?
ALNYLAM PHARMACEUTICALS, INC. prepaid & other current assets grew at a compound annual growth rate (CAGR) of 35.04% from FY2020 to FY2025, going from $62.8M to $281.9M over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $281.9M | +141.0% | 10-K |
| FY2024 | $117.0M | -7.5% | 10-K |
| FY2023 | $126.4M | -4.9% | 10-K |
| FY2022 | $132.9M | +50.9% | 10-K |
| FY2021 | $88.1M | +40.3% | 10-K |
| FY2020 | $62.8M | -21.9% | 10-K |
| FY2019 | $80.3M | +9.0% | 10-K |
| FY2018 | $73.7M | +83.7% | 10-K |
| FY2017 | $40.1M | +84.5% | 10-K |
| FY2016 | $21.7M | +31.3% | 10-K |
| FY2015 | $16.6M | +70.0% | 10-K |
| FY2014 | $9.7M | +149.1% | 10-K |
| FY2013 | $3.9M | +48.0% | 10-K |
| FY2012 | $2.6M | -36.5% | 10-K |
| FY2011 | $4.2M | -39.6% | 10-K |
| FY2010 | $6.9M | - | 10-K |